Bolingbrook, ILNCT07540312Now EnrollingIRB Ready

IBS (Irritable Bowel Syndrome) Clinical Trial in Bolingbrook, IL

Access cutting-edge ibs (irritable bowel syndrome) treatment through this clinical trial at a research site in Bolingbrook. Study-provided care at no cost to qualified participants.

Sponsored by PGP Health

Quick Self-Assessment

See if you qualify for this Bolingbrook location

Preparing your pre-screening questions…

Expert Care in Bolingbrook

Access ibs (irritable bowel syndrome) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related ibs (irritable bowel syndrome) treatment provided free

Apply for This Bolingbrook Location

Check if you qualify for this ibs (irritable bowel syndrome) clinical trial in Bolingbrook, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Bolingbrook

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Bolingbrook site if eligible
  4. 4Begin participation

About This IBS (Irritable Bowel Syndrome) Study in Bolingbrook

This prospective, interventional trial is intended to determine the safety and effectiveness of the Variable Compression System (VCS) device for Irritable Bowel Syndrome (IBS). This pilot study will enroll 20 subjects who will be required to wear the VCS device for a minimum of 6 hours a day and follow up at 21 days, 8 weeks, and 6 months post-device administration.

Sponsor: PGP Health

Who Can Participate

Inclusion Criteria

Written informed consent to participate in the trial as prescribed.
Subjects with a weight of ≥50 kg and a body mass index between 18 and 40 kg/m2.
Diagnosed with IBS(C)-constipation, IBS(D)-diarrhea, or IBS(M)-mixed patients' diagnosis according to Rome Criteria (moderate to severe).

Exclusion Criteria

Allergy to the investigational device or any components or clinically significant allergies (excluding mild seasonal allergies), in the opinion of the investigator.
Clinically relevant history of gastrointestinal, cardiovascular, musculoskeletal, endocrine, hematologic, psychiatric, renal, hepatic, bronchopulmonary, neurologic, immunologic, lipid metabolism disorders, or psychiatric disorders making implementation of the protocol or interpretation of the trial results difficult, or that would put the participant at risk by participating in the trial in the opinion of the Investigator.
Hospital admission or major surgery within 30 days prior to screening.
Pregnant, or positive urine pregnancy test.
Participation in any other investigational drug trial within 30 days prior to screening.
Participant with substance use disorder (SUD) and/or alcohol use disorder (AUD).
Participant who has other conditions that may affect compliance in the opinion of the investigator, or who are unable to participate in the trial on his/her own.
Participant with end stage organ disease.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Bolingbrook?

Yes, this clinical trial (NCT07540312) has an active research site in Bolingbrook, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

IBS (Irritable Bowel Syndrome) Treatment Options in Bolingbrook, IL

If you're searching for ibs (irritable bowel syndrome) treatment options in Bolingbrook, IL, this clinical trial (NCT07540312) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Bolingbrook research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ibs (irritable bowel syndrome) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all ibs (irritable bowel syndrome) clinical trials near you to find additional studies recruiting in your area.

More IBS Trials in Bolingbrook, IL

See all ibs clinical trials recruiting in Bolingbrook — not just this study.

Browse IBS Trials in Bolingbrook →

Browse More Trials by Condition

IBS TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Bolingbrook?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Bolingbrook, IL